Dataset Information


Altertoxin II, a Highly Effective and Specific Compound against Ewing Sarcoma.

ABSTRACT: A screening program designed to identify natural products with selective cytotoxic effects against cell lines representing different types of pediatric solid tumors led to the identification of altertoxin II as a highly potent and selective cytotoxin against Ewing sarcoma cell lines. Altertoxin II, but not the related compounds altertoxin I and alteichin, was highly effective against every Ewing sarcoma cell line tested, with an average 25-fold selectivity for these cells as compared to cells representing other pediatric and adult cancers. Mechanism of action studies revealed that altertoxin II causes DNA double-strand breaks, a rapid DNA damage response, and cell cycle accumulation in the S phase. Our studies also demonstrate that the potent effects of altertoxin II are partially dependent on the progression through the cell cycle, because the G1 arrest initiated by a CDK4/6 inhibitor decreased antiproliferative potency more than 10 times. Importantly, the cell-type-selective DNA-damaging effects of altertoxin II in Ewing sarcoma cells occur independently of its ability to bind directly to DNA. Ultimately, we found that altertoxin II has a dose-dependent in vivo antitumor efficacy against a Ewing sarcoma xenograft, suggesting that it has potential as a therapeutic drug lead and will be useful to identify novel targets for Ewing-sarcoma-specific therapies.

PROVIDER: S-EPMC8699301 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC9247831 | BioStudies
| S-EPMC4675330 | BioStudies
| S-EPMC6445779 | BioStudies
| S-EPMC3432289 | BioStudies
| E-GEOD-38392 | BioStudies
| S-EPMC4587665 | BioStudies
2012-01-01 | S-EPMC3271129 | BioStudies
| S-EPMC8563374 | BioStudies
| S-EPMC4745789 | BioStudies
| S-EPMC8616448 | BioStudies